Table 1.
MST ± s.e.m. (days) | ||
---|---|---|
Group | A. 5 × 105 CFU/mouse | B. 2 × 105 CFU/mouse |
1. Non-vaccinated control | 24·8 ± 1·3 | 31·6 ± 2·9 |
2. M. bovis BCG-Prague | > 70 | > 90 |
3. M. smegmatis::p16R1 | 25·1 ± 0·7 | 66·3 ± 4·7 |
4. M. smegmatis::p16R1-19 | 24·1 ± 0·7 | 42·9 ± 5·9* |
5. M. smegmatis::cosmid 19-kD | 29·5 ± 1·7 | 52·5 ± 3·2* |
6. M. vaccae::p16R1 | ND | 57·8 ± 2·0 |
7. M. vaccae::p16R1-19 | ND | 46·6 ± 2·5* |
8. VIJNS-Tpa | 20·0 ± 0·72 | ND |
9. VIJNS-Tpa19 | 28·9 ± 2·61** | ND |
Significant decrease in mean survival time (MST) compared with the corresponding vector control group.
Significantly different from the plasmid control group (P < 0·01 by Student's t-test).